NCT06316180View on ClinicalTrials.gov

The Use of Drospirenone/Estetrol in Random Start Rapid Endometrial Preparation

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

August 1, 2023

Study Completion Date

March 1, 2024

Conditions
Endometrial PolypEndometrial Diseases
Interventions
DRUG

drospirenone/estetrol 3mg/14.2mg

Hysteroscopic polipectomy after starting 14-day treatment with oral drospirenone/estetrol 3mg/14.2mg at any time of the menstrual cycle.

Trial Locations (2)

90123

Andrea Etrusco, Palermo

00161

Marco Monti, Rome

All Listed Sponsors
collaborator

University of Roma La Sapienza

OTHER

lead

University of Palermo

OTHER